Category: Diagnostics
Global Diagnostics
-
Oncology Molecular Diagnostics
... at a CAGR of 11.1% over the analysis period 2024-2030. Breast Cancer, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$2.9 Billion by the end of ... Read More
-
Optical Coherence Tomography (OCT) for Ophthalmology
... reach US$1.1 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Conventional OCT Systems, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and ... Read More
-
Creatinine Assay Kits
... at a CAGR of 2.2% over the analysis period 2024-2030. Jaffe`s Kinetic Test Kits, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$102.1 Million by the ... Read More
-
Dental Radiology Equipment
... at a CAGR of 4.1% over the analysis period 2024-2030. Extraoral X-Ray Systems, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$6.3 Billion by the end ... Read More
-
Flow Chemistry
... CAGR of 8.8% over the analysis period 2024-2030. CSTR, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$1.1 Billion by the end of the analysis period. ... Read More
-
Endoscopic Ultrasound Needles
... at a CAGR of 2.7% over the analysis period 2024-2030. Aspiration Needles (EUS-FNA), one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$150.5 Million by the end ... Read More
-
Medical Imaging Information Systems
... 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Computed Tomography, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$390.1 Million by the ... Read More
-
Ophthalmic Ultrasound Systems
... at a CAGR of 3.9% over the analysis period 2024-2030. Portable, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$2.4 Billion by the end of the ... Read More
-
Hybrid Operating Rooms
... at a CAGR of 12.2% over the analysis period 2024-2030. Cardiovascular, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$1.2 Billion by the end of the ... Read More
-
Hyperspectral Imaging Systems
... at a CAGR of 18.7% over the analysis period 2024-2030. Cameras, one of the segments analyzed in the report, is expected to record a 19.6% CAGR and reach US$53.0 Billion by the end of the ... Read More
-
In Vitro Diagnostics
... at a CAGR of 3.4% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$86.3 Billion by the end ... Read More
-
Industrial Microbiology
... CAGR of 4.6% over the analysis period 2024-2030. Pharmaceuticals, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$11.6 Billion by the end of the analysis period. ... Read More
-
Intraoperative Imaging
... CAGR of 4.4% over the analysis period 2024-2030. Mobile C-Arms, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$1.8 Billion by the end of the analysis ... Read More
-
Life Science Instrumentation
... at a CAGR of 4.6% over the analysis period 2024-2030. Spectroscopy, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$24.4 Billion by the end of the ... Read More
-
Modular Laboratory Automation
... at a CAGR of 6.5% over the analysis period 2024-2030. Automated Liquid Handlers, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$1.4 Billion by the end ... Read More
-
Pneumonia Testing
... CAGR of 6.2% over the analysis period 2024-2030. Immunodiagnostics, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$339.9 Million by the end of the analysis period. ... Read More
-
Poultry Diagnostics
... CAGR of 9.0% over the analysis period 2024-2030. ELISA, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$558.3 Million by the end of the analysis period. ... Read More
-
Drug Abuse Testing
... at a CAGR of 5.3% over the analysis period 2024-2030. Laboratory Services, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$52.0 Billion by the end of ... Read More
-
Inorganic Scintillators
... CAGR of 5.5% over the analysis period 2024-2030. Sodium Iodide (NaI), one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$200.2 Million by the end of the ... Read More
-
In-Vitro Colorectal Cancer Screening Tests
... Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Fecal Occult Blood Test, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach ... Read More
-
Coagulation Testing
... CAGR of 4.8% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.7 Billion by the end of the analysis period. ... Read More
-
Hematology Diagnostics
... CAGR of 5.8% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$7.8 Billion by the end of the analysis period. ... Read More
-
Veterinary Ultrasound Scanners
... at a CAGR of 4.9% over the analysis period 2024-2030. Portable Ultrasound Scanners, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$327.4 Million by the end ... Read More
-
Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
... forecasts spanning 2024-2029. Immunoassays—diagnostic tests that detect target analytes via antibody-antigen interactions—are foundational tools in clinical laboratories and point-of-care (POC) settings, enabling the detection of proteins, hormones, drugs, and infectious agents. The global immunoassay market ... Read More
-
Immunofluorescence Assays
... CAGR of 4.4% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$3.8 Billion by the end of the analysis period. ... Read More